Koji Abe - NEXON G Counsel
7NX Stock | EUR 13.30 1.00 6.99% |
Insider
Koji Abe is G Counsel of NEXON Co
Phone | 81 3 6629 5318 |
Web | https://www.nexon.co.jp |
NEXON Management Efficiency
The company has return on total asset (ROA) of 0.0639 % which means that it generated a profit of $0.0639 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1167 %, meaning that it generated $0.1167 on every $100 dollars invested by stockholders. NEXON's management efficiency ratios could be used to measure how well NEXON manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Matthew Palmieri | Universal Insurance Holdings | 43 | |
Christoph Nowak | Diamyd Medical AB | 37 | |
Martina Widman | Diamyd Medical AB | 42 | |
Jing Yang | Genertec Universal Medical | 56 | |
Xiaohong Ge | Genertec Universal Medical | N/A | |
Gary Ropiecki | Universal Insurance Holdings | N/A | |
Wang Wenbing | Genertec Universal Medical | 49 | |
Anton Lindqvist | Diamyd Medical AB | 43 | |
ACS ACIS | Genertec Universal Medical | N/A | |
Jason Burns | Universal Insurance Holdings | 43 | |
Anna BSc | Diamyd Medical AB | 62 | |
Eva Karlstrom | Diamyd Medical AB | 59 | |
Michael Poloskey | Universal Insurance Holdings | 52 | |
Inder BCom | QBE Insurance Group | N/A | |
Jason BSc | QBE Insurance Group | 56 | |
Matt MBA | QBE Insurance Group | N/A | |
Ashley Dalziell | QBE Insurance Group | N/A | |
Samuel BA | QBE Insurance Group | 53 | |
Ulf MBA | Diamyd Medical AB | 48 | |
MAICD FCPA | QBE Insurance Group | N/A | |
BA ACA | QBE Insurance Group | N/A |
Management Performance
Return On Equity | 0.12 | |||
Return On Asset | 0.0639 |
NEXON Leadership Team
Elected by the shareholders, the NEXON's board of directors comprises two types of representatives: NEXON inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NEXON. The board's role is to monitor NEXON's management team and ensure that shareholders' interests are well served. NEXON's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NEXON's outside directors are responsible for providing unbiased perspectives on the board's policies.
Patrick Soderlund, Independent Director | ||
Owen Mahoney, President, Chief Executive Officer, Representative Director | ||
Koji Abe, G Counsel | ||
Shiro Uemura, Chief Financial Officer, Chief Director of Business Administration, Representative Director | ||
Junko Tomita, Investor Officer | ||
Takanori Kawai, Team Relations | ||
Dohwa Lee, Director | ||
Maiko Ara, Head PR | ||
Shiro Kuniya, Independent Director | ||
Satoshi Honda, Independent Director | ||
Nicolas Dyk, Chief VP |
NEXON Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is NEXON a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.12 | |||
Return On Asset | 0.0639 | |||
Profit Margin | 0.28 % | |||
Operating Margin | 0.29 % | |||
Current Valuation | 14.65 B | |||
Shares Outstanding | 864.61 M | |||
Shares Owned By Insiders | 50.21 % | |||
Shares Owned By Institutions | 28.05 % | |||
Price To Earning | 35.10 X | |||
Price To Book | 2.95 X |
Currently Active Assets on Macroaxis
BTC | Bitcoin | |
TRX | TRON | |
BNB | Binance Coin | |
ADA | Cardano | |
XRP | XRP |
Other Information on Investing in NEXON Stock
NEXON financial ratios help investors to determine whether NEXON Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NEXON with respect to the benefits of owning NEXON security.